Home > Interest Group > Medical Technology
| Diseases | |
 |
Correctal Cancer (Life Science Technology and Patenting Report) |
|
Influenza(Life Science Technology and Patenting Report) |
| Drugs | |
|
Pharma Patent (Drug:Crestor /Rosuvastatin) |
|
Pharma Patent (Drug:Cozaar/Iosartan /Avastar /Hyzaar) |
For more information, please contact Mr. Rajdev Narayanasamy, Senior Regional Sales Manager, Rajdev.Narayanasamy@thomsonreuters.com
The Image-guided surgical systems as well as surgical robots are aiding surgeons to perform procedures with extraordinary precision and adroitness. The major advantage of using these systems is that it helps the surgeons to handle most complicated surgeries with superior precision tools. The rate of acceptance of these systems is quite encouraging and in the near future, it is expected that they will ultimately dictate the way most of the surgeries are performed.
eHealth is short for electronic health. It is a recent world concept and is having far reaching effects all over the world. Telemedicine and healthcare information systems (HIS) make up the quintessential crux of the eHealth industry in the present day, these two mutually exclusive, but collectively exhaustive technologies are having a mushroom growth and leaving their footprints on the healthcare-information technology (HC-IT) industry.
Chronic dermal wounds are difficult to manage and slow to heal, inflicting pain, resulting in loss of quality of life, and are potentially life-threatening. Numerous surgical wounds become delayed healing wounds particularly in the elderly or in diabetic patients. Advanced wound healing products/devices designed to improve the healing of chronic wounds aid in faster healing and recovery of patients in conjunction with the potential to reduce economic costs associated with lengthy hospitalization.
Understanding host-pathogen interactions provides insights into potential target sites that facilitate the design of feasible antimicrobial strategies against important pathogens. This is exemplified by a strong causative link between peptic ulcers, gastritis, and gastric cancers with Helicobacter pylori infections.
Research on infectious diseases is a critical element in our defence against newly emerging and re-emerging microbial threats, a point brought home most devastatingly by the avian influenza and SARS epidemics. Flaviviruses, in particular dengue and West Nile viruses, are of significant medical importance given the increasing prevalence of mosquito-borne diseases with global warming. In addition, malaria kills some two to three million people every year. Antibiotic resistance represents a serious international problem, and is an area of intense public health interest.
Some of the above listed strategic research areas of infectious disease research are being focused on by NUS researchers based on their importance to Singapore, the region or globally. This strategic thrust in infectious disease research is embodied in NUS’ Infectious Disease Programme. Eight Area of research have been identified.
Cancer is one of the leading causes of deaths in Singapore as well as in the rest of the world. At NUS, the
Oncology Research Institute (ORI) and the University Cancer Program (UCP) focus on cancers common in the region with emphasis on a seamless transfer of knowledge from bench to patient, complementing work being done in University affiliated Research Institutes.
Several departments in the Yong Loo Lin School of Medicine, including Department of Anatomy, Department of Biochemistry, Department of Community, Occupational & Family Medicine, Department
of Diagnostic Radiology, Department of Medicine, Department of Pediatric, Department of Pathology, Department of Physiology and Department of Surgery focus one of their thrusts on Cancer.
